MedPath

The Long-term Neurodevelopmental Outcome After Intraventricular Hemorrhage (IVH)-Grades I-II in Preterm Infants at Ages 1-7 Years

Conditions
Premature Infants
Interventions
Other: Telephone interview
Registration Number
NCT01912703
Lead Sponsor
Hillel Yaffe Medical Center
Brief Summary

It is well-known that preterm delivery can be accompanied by complications. One of these complications is Intraventricular Hemorrhage (IVH). There are four degrees of IVH, according to severity. It is known that IVH Grades 3-4 can cause severe neurodevelopmental outcomes, including cerebral palsy (CP), hemiplegia, lower motor and cognitive skills and social difficulties. It is not known whether IVH Grades I-II have any of these effects and the aim of this study is to determine whether they do have any neurodevelopmental outcomes.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
700
Inclusion Criteria
  • All preterm infants born at 35 weeks or less
  • Underwent at least 1 brain ultrasound
  • Diagnosed with IVH Grades 1-2
  • Had no other severe illness in NICU
  • Had neurodevelopmental follow-up
Exclusion Criteria
  • All others

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Preterm infants with IVH Grades I-IITelephone interviewPreterm infants (post-menstrual age 24-35 weeks) who were diagnosed with IVH Grades 1-2 in the neonatal intensive care unit (NICU).
Control GroupTelephone interviewPreterm infants (post-menstrual age 24-35 weeks) who had no imaging evidence of IVH in the neonatal intensive care unit (NICU).
Primary Outcome Measures
NameTimeMethod
General Neurodevelopmental AssessmentSeven years

Retrospective study of preterm infants born in the years 2007-2011 and suffered IVH Grades 1-2 who have undergone a general neurodevelopmental assessment in the Institute for Child Development in Hillel Yaffe Medical Center at ages 1-7. This assessment will indicate whether IVH Grades 1-2 has any neurodevelopmental effect on these children.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Hillel Yaffe Medical Center

🇮🇱

Hadera, Israel

© Copyright 2025. All Rights Reserved by MedPath